Gérard Jaouen
Gérard Jaouen publishes mostly in Organic Chemistry, Molecular Biology and Oncology, on topics such as Ferrocene Chemistry and Applications, Metal complexes synthesis and properties and Organometallic Complex Synthesis and Catalysis.
- World rank
- #1,909,543 of 7,710,434 ranked researchers
- Rank in France
- #83,558 of 324,115
- Works
- 655
- Citations
- 16k
- Citations per work
- 25.2
What does Gérard Jaouen research?
Gérard Jaouen's work is mostly in Chemistry (51%), Medicine (14%), Biochemistry, Genetics and Molecular Biology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences33350.9%
- Chemistry33350.9%
- Everything else15523.7%
- Health Sciences9013.7%
- Medicine9013.7%
- Life Sciences7711.7%
- 1Organic Chemistry42% of their works
- 2Molecular Biology12% of their works
- 3Oncology10% of their works
- 4Inorganic Chemistry4% of their works
- 5Spectroscopy4% of their works
- 6Radiology, Nuclear Medicine and Imaging3% of their works
Research topics
- Ferrocene Chemistry and Applications
- Metal complexes synthesis and properties
- Organometallic Complex Synthesis and Catalysis
- Synthesis and Biological Evaluation
- Chemical Synthesis and Analysis
- Inorganic and Organometallic Chemistry
- Radiopharmaceutical Chemistry and Applications
- Advanced biosensing and bioanalysis techniques
Which keywords describe Gérard Jaouen's research?
The keywords of their largest research topics: Organometallic Chemistry, Medicinal Chemistry, Cancer Research, Ferrocene, Anticancer Agents, Metal Complexes, Cisplatin Resistance and Platinum-Based Drugs.
- Self-Assembly
- Radiopharmaceuticals
- Organic Synthesis
- Peptide Synthesis
- Synthesis
- Transition Metal
- Heterocyclic Compounds
- Platinum-Based Drugs
- Metal Complexes
- Ferrocene
- Medicinal Chemistry
- Organometallic Chemistry
- Cancer Research
- Anticancer Agents
- Cisplatin Resistance
- Catalysis
- Polymerization
- Quinoxaline
- Drug Discovery
- Functional Group Transformations
- PET Imaging
- DNA nanotechnology
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Organometallic Chemistry3312 topics
- Medicinal Chemistry3082 topics
- Cancer Research2331 topic
- Ferrocene2331 topic
- Anticancer Agents2202 topics
- Metal Complexes1902 topics
- Cisplatin Resistance1451 topic
- Platinum-Based Drugs1451 topic
- Catalysis1432 topics
- Heterocyclic Compounds1202 topics
- Polymerization981 topic
- Transition Metal981 topic
- Quinoxaline751 topic
- Synthesis751 topic
- Drug Discovery711 topic
- Peptide Synthesis711 topic
- Functional Group Transformations451 topic
- Organic Synthesis451 topic
- PET Imaging441 topic
- Radiopharmaceuticals441 topic
- DNA nanotechnology401 topic
- Self-Assembly401 topic
Where does Gérard Jaouen work?
Gérard Jaouen's main affiliation in the publication record is Chimie ParisTech, France.
How many publications and citations does Gérard Jaouen have?
OpenAlex counts 655 works and 16,493 citations for Gérard Jaouen, an h-index of 61, ranking #1,909,543 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Gérard Jaouen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.